Reconstitution of solubilised brain D2 dopamine receptors into phospholipid vesicles  by Wheatley, M. & Strange, P.G.
Volume 166, number 2 FEBS 1189 January 1984 
Reconstitution of solubilised brain Da dopamine receptors into 
phospholipid vesicles 
M. Wheatley and P.G. Strange* 
Department of Biochemistry, University of Nottingham Medical School, Queen’s Medical Centre, Nottingham NG7 
2UH, England 
Received 2 December 1983 
Dz dopamine receptors have been solubilised from bovine caudate nucleus using cholate/sodium chloride 
in the presence of soyabean phospholipid. Reconstitution of the receptors into soyabean phospholipid 
vesicles has been achieved by dialysis to remove detergent and salt. The receptors are truly reconstituted 
as judged by sedimentation, electron microscopy, heat stability and analysis on sucrose density gradients. 
The ligand-binding properties of the reconstituted receptors resemble those of the solubilised preparation. 
DZ dopamine receptor Solubilisation 
1. INTRODUCTION 
In vitro techniques have recently been used in- 
tensively for studying brain dopamine receptors 
and the D2 class, which shows a high affinity for 
dopamine antagonists, has been implicated in 
many of the important physiological functions of 
dopamine [l-4]. More recently brain D2 dopamine 
receptors have been solubilised in an active form 
using a variety of detergents and purification 
studies are in progress [5,6]. The integrity of the 
solubilised receptors can partly be ascertained 
from the ability of the solubilised receptors to bind 
dopamine receptor-specific ligands but it will be 
desirable, however, to demonstrate functional in- 
teraction of the solubilised receptors with the other 
components of the dopamine transmembrane 
signalling system and one approach to this is to 
reconstitute the solubilised receptors into defined 
phospholipid vesicles [7]. This will also enable the 
influence of the membrane environment on recep- 
tor properties to be established. Here we describe 
the first report of reconstitution of solubilised 
dopamine D2 receptors. 
* To whom correspondence should be addressed 
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2. EXPERIMENTAL 
Mixed mitochondrial-microsomal membrane 
preparation from bovine caudate nucleus, ob- 
tained as in [8,9] was sedimented (130000 x g, 
60 min) and the supernatant discarded. The pellet 
was resuspended at a protein concentration of 1 
mg/ml (Teflon/steel homogeniser, 0.18 mm radial 
clearance, 800 rpm, 5 strokes) in an ice-cold 
medium containing cholate (5.7 mg/ml), sodium 
chloride (1 M), crude soyabean phosphatidyl- 
choline (5 mg/ml, Sigma, type 11-S), Hepes 
(N-2-hydroxyethylpiperazine-N’ -2-ethanesul- 
pho-nit acid) (20 M, pH 7.4), EDTA (1 mM), 
EGTA (1 mM), MgCl2 (20 mM), dithiothreitol(O.1 
mM). Phenylmethylsulphonyl fluoride (0.1 mM) 
was added just prior to solubilisation. This 
medium was sonicated before use to clarify the 
solution. The resuspended material was stirred 
gently at 4°C for 60 min and then centrifuged 
(135000 x g, 90 min) and the upper 75% of the 
supernatant aken as the solubilised preparation. 
The solubilised preparation was dialysed in 
Visking 8/32 tubing at 4°C against approximately 
100 vols of buffer (Hepes 20 mM), EDTA (1 mM), 
EGTA (1 mM), magnesium chloride (20 mM), 
sodium chloride (1 M), dithiothreitol(O.1 mM, pH 
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7.4) for 28 h changing the buffer 3 times, followed 
by the same buffer minus the sodium chloride for 
12 h. The turbid dialysate was centrifuged (136000 
x g, 90 min) and the pellet resuspended in the low 
salt buffer used for dialysis by gentle homogenisa- 
tion (Teflon/steel) to give the reconstituted 
preparation (protein concentration approx. 0.6 
mg/ml). 
[3H]Spiperone (- 1 nM) binding was assayed 
essentially as in [lo] except that assays on 
reconstituted material were performed at 25°C 30 
min and the density of the preparation was raised 
to about 20% sucrose (equivalent to about 17% 
sucrose in the binding assay) in order to prevent 
sedimentation of liposomes during the centrifuga- 
tion stage of the assay. This did not hinder cen- 
trifugation of the charcoal during the assay. 
Specific [3H]spiperone binding was defined as the 
difference in binding between assays containing 1 
,uM (-)- and ( +)-butaclamol. 
3. RESULTS AND DISCUSSION 
Initially DZ receptors from bovine caudate 
nucleus, assayed by [3H]spiperone binding [B] and 
solubilised with cholate (0.2%), sodium chloride (1 
M) [B] were mixed with sonicated crude soyabean 
phosphatidylcholine and dialysed to remove the 
detergent. No incorporation of protein or D2 
receptors into the vesicle preparation formed on 
dialysis was achieved in this way and it seems that 
it is important that detergent, lipid and protein are 
thoroughly co-solubilised prior to dialysis in order 
to achieve incorporation into the vesicles formed 
upon dialysis. In order to achieve this, Dz receptors 
from bovine caudate nucleus membranes were 
solubilised by cholate (0.57%), sodium chloride (1 
M) in the presence of 0.5% crude soyabean 
phosphatidylcholine and using this method ap- 
prox. 60% solubilisation of protein is achieved and 
a preparation containing active solubilised D2 
receptors is obtained (table 1). Displacement ex- 
periments using selective substances indicated that 
the specific [3H]spiperone binding was solely to D2 
receptors with no SZ serotonin receptor compo- 
nent. The receptors are truly solubilised as judged 
by ultrafiltration through 200 nm filters (110% 
recovery of D2 receptors, 93% recovery of protein, 
95% recovery of lipid) and electron microscopy. 
When this preparation was dialysed against 
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Table 1 
Displacement of specific [3H]spiperone binding from 
solubilised and reconstituted preparations of Dz 
dopamine receptors 
Substance IGO (nM) 
Solubilised Reconstituted 
( + )-Butaclamol 132 224 
( - )-Butaclamol > 10000 > 10000 
Domperidone 219 263 
Mianserin > 10000 > 10000 
Pipamperone 1514 447 
Spiperone 12 11 
Sulpiride 1413 537 
I& (concentration of substance giving half-maximal 
displacement of specific [3H]spiperone binding) values 
were determined in solubilised and reconstituted 
preparations 
detergent-free low ionic strength buffer, however, 
there was still very little incorporation of protein 
or receptors into the vesicles formed. 
The procedure was, therefore, modified by in- 
cluding 20 mM Mg2+ during solubilisation and 
dialysis, using a two stage dialysis against high and 
low salt buffer in order to ensure removal of 
detergent before salt and using as rapid a dialysis 
time as possible (using small diameter dialysis tub- 
ing) and these changes achieved incorporation (34 
* 7% incorporation, mean f SD, based on 
solubilised preparation). The vesicles formed upon 
dialysis were collected by centrifugation and con- 
tained about half of the protein from the solubi- 
lised preparation. Active receptor were found only 
in the vesicle preparation, none being found in the 
supernatant, so that the presence of receptors in 
the vesicle preparation is unlikely to be due to oc- 
clusion or sticking. Receptors in the vesicle prepa- 
ration may be assayed by [3H]spiperone binding 
either by the charcoal adsorption technique, 
modified as stated above, or by trapping on glass 
fibre (GF/C) filters. No specific [3H]spiperone 
binding is observed in a control vesicle preparation 
formed by a dialysis of solubilised lipid in the 
absence of added protein from the solubilised 
receptor preparation. 
The D2 receptors are likely, therefore, to be 
reconstituted into vesicles and we have verified this 
in several ways. The reconstituted D2 receptors 
sediment upon centrifugation (200000 x g, 1 h) 
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Fig. 1. Electron micrograph of reconstituted prepara- 
tion. Reconstituted preparation was examined by 
negative staining (phosphotungstic acid) in a Philips 410 
electron microscope. The magnification is 58000 x . 
whereas solubilised receptors do not under these 
conditions. Examination of the reconstituted 
preparation reveals a heterogeneous population of 
mainly unilamellar vesicles (diameter 118 + 37 
nm, mean + SD) (fig.1) whereas the solubilised 
preparation shows no such vesicles. The 
reconstituted preparation is stable at 25°C for 30 
min whereas the solubilised preparation is not. If 
tracer quantities of [14C]phosphatidylcholine are 
included with the bulk lipid during solubilisation 
and reconstitution, and the reconstituted prepara- 
tion analysed on a 5-25% sucrose density gradient 
(fig.2) comigration of lipid and receptors is ob- 
served. Thus the receptors are truly reconstituted 
rather than aggregated. The small amount of 
receptors in the 18Yo sucrose region of the gradient 
may represent limited aggregation of receptors as 
more receptor material (non-vesicular by electron 
microscopy) is found in this region if a lower 
phospholipid/protein ratio is employed during 
solubilisation and reconstitution. 
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Fig. 2. Sucrose density gradient centrifugation of reconstituted receptors. Reconstitution f solubilised DZ receptors was 
performed as described except hat 1.7 nCi of [‘4C]dioleoylphosphatidylcholine was included during solubilisation. 
Two-ml samples of reconstituted material were loaded on to sucrose density gradients (S-25%, w/v, sucrose in Hepes 
(20 mM), EDTA (1 mM), EGTA (I mM), magnesium chloride (20 mM) (total vol. 14 ml) and centrifuged (18 ‘1, 94500 
x g, 4°C). The gradients were unloaded by displacement with 3Wo sucrose, 1 ml fractions collected and assayed for 
sucrose concentration, 14C radioactivity, and specific [3Hlspiperone binding (after increasing the sucrose concentration 
to 20%). 
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The reconstituted D2 receptors have been anal- 
ysed pharmacologically (table 1) in displacement 
experiments in order to determine the effect of the 
manipulations on the properties of the receptors. 
Specific [3H]spiperone binding represents about 
40% of the total binding and the high non-specific 
binding is likely to be associated with the large 
amounts of phospholipid present. Phar- 
macologically the reconstituted receptors resemble 
the solubilised preparation quite closely. Thus 
specific [3H]spiperone binding is displaced by the 
selective DZ receptor antagonists domperidone and 
sulpiride whereas the selective SZ serotonin recep- 
tor antagonist mianserin is virtually inactive. The 
affinity for the selective S2 antagonist 
pipamperone increases slightly on reconstitution 
but this is unlikely to be due to SZ receptors in the 
preparation owing to the data obtained with the 
other ligands. 
Reconstitution into vesicles of crude soyabean 
phospholipid does not, therefore, elicit any major 
changes in the properties of the receptors relative 
to those in the solubilised preparation and ligand- 
binding affinities are still somewhat lower than in 
the corresponding membrane-bound preparations 
[5,8]. The receptor may show a specificity for par- 
ticular phospholipids but this question remains 
unanswered until the effect of a range of 
phospholipids on the properties of the 
reconstituted receptors can be studied. Never- 
theless, the approach described here for the first 
time should be very powerful in determining the 
mechanism of action and constitution of the D2 
receptor. 
ACKNOWLEDGEMENTS 
We thank the MRC for financial support, An- 
nette Tomlinson for electron microscopy and 
Millie Spooner for preparing the manuscript. 
REFERENCES 
Ul 
121 
131 
141 
PI 
@I 
[71 
PI 
[91 
1101 
Seeman, P. (1980) Pharmacol. Rev. 32, 229-313. 
Creese, I. (1982) Trends Neurosci. 5, 40-43. 
Strange, P.G. (1983) in: Cell Surface Receptors 
(Strange, P.G. ed.) pp. 82-100, Ellis Horwood, 
Chichester. 
Laduron, P. (1980) Trends Pharmacol. Sci. 1, 
471-474. 
Strange, P.G. (1983) Trends Pharmacol. Sci. 4, 
188-190. 
Laduron, P. and Ilien, B. (1982) Biochem. 
Pharmacol. 31, 2145-2151. 
Citri, Y. and Schramm, M. (1980) Nature 287, 
297-300. 
Hall, J.M., Frankham, P.A. and Strange, P.G. 
(1983) J. Neurochem. 41, 1526-1532. 
Withy, R.M., Mayer, R.J. and Strange, P.G. 
(1982) J. Neurochem. 38, 1348-1355. 
Wheatley, M. and Strange, P.G. (1983) FEBS Lett. 
151, 97-101. 
392 
